Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RTI Surgical Inc gives Q2 2014 guidance above analysts' estimates; raises FY 2014 guidance


Thursday, 24 Apr 2014 08:00am EDT 

RTI Surgical Inc:Expects Q2 2014 revenues to be between $62 million and $63 million.Expects Q2 2014 net income per fully diluted common share to be about $0.02.Expects FY 2014 revenues to be between $248 million and $253 million, as compared to prior guidance of between $245 million and $250 million.Expects FY 2014 on non-GAAP basis, net income per fully diluted common share to be in the range of $0.07 to $0.09, as compared to prior guidance of $0.06 to $0.08.Q2 2014 revenue of $58 million and EPS of $0.00 - Thomson Reuters I/B/E/S.FY 2014 revenue of $237 million and EPS of $0.07 - Thomson Reuters I/B/E/S. 

Company Quote

6.14
-0.24 -3.76%
4:00pm EDT